Evidence map›Paper›PMID 20938371›Full record

ArticlePharmacogenetics and genomics2011

Platelet aggregation pathway.

Katrin Sangkuhl, Alan R Shuldiner, Teri E Klein, Russ B Altman

Abstract read
In one paragraph

Article in Pharmacogenetics and genomics, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 50 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
50citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

50 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Trial
  3. Trial
  4. Frontiers in pharmacology · 2025
    Article
  5. Article
  6. Article
  7. Circulation · 2024
    Review
  8. Wound Modulations in Glaucoma Surgery: A Systematic Review.Bioengineering (Basel, Switzerland) · 2024
    Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. Article
  15. Article
  16. Review
  17. Review
  18. Article
  19. COVID-19 andJournal of ginseng research · 2022
    Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Katrin SangkuhlDepartment of Genetics, Stanford University, Stanford, California, USA.
Alan R Shuldiner
Teri E Klein
Russ B Altman

Funding

PharmGKB: pharmacogenomics knowledge for precision medicineR24GM061374 · NIGMS · STANFORD UNIVERSITY · PI ALTMAN, RUSS BIAGIO, KLEIN, TERI ELLEN · 2010 to 2018
$25.2M
THE STANFORD PHARMACOGENETICS KNOWLEDGE BASEU01GM061374 · NIGMS · STANFORD UNIVERSITY · PI ALTMAN, RUSS BIAGIO · 2000 to 2009
$24.0M
Genome-wide Search for CVD Gene-Environment InteractionsU01HL072515 · NHLBI · UNIVERSITY OF MARYLAND BALTIMORE · PI SHULDINER, ALAN R. · 2002 to 2008
$11.2M
NHLBI NIH HHS U01 HL072515NIGMS NIH HHS GM61374NIGMS NIH HHS R24 GM061374NIGMS NIH HHS U01 GM061374
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Aryl Hydrocarbon HydroxylasesAspirinClopidogrelCyclooxygenase 1Cytochrome P-450 CYP2C19Drug ResistanceHumansIntegrin beta3Metabolic Networks and PathwaysPlatelet AggregationPlatelet Aggregation InhibitorsPlatelet Membrane Glycoprotein IIbPolymorphism, Single NucleotideTiclopidineAryl Hydrocarbon HydroxylasesAspirinClopidogrelCyclooxygenase 1CYP2C19 protein, humanCytochrome P-450 CYP2C19Integrin beta3Platelet Aggregation InhibitorsPlatelet Membrane Glycoprotein IIbPTGS1 protein, humanTiclopidine

Identifiers

PMID20938371
PMCPMC3134593

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.